Merus

MRUS

MRUS Merus NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    MRUS Chart
    See on advanced chart >

    About

    Merus N.V. was incorporated under the laws of the Netherlands on June 16, 2003.The company is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics. Their pipeline of full-length human bispecific antibody candidates,...
    • Highlight
      A clinical-stage oncology company that developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®)
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      05/19/2016
    • Established Date
      06/16/2003
    • Full-time Employees
      172
    • Address
      Uppsalalaan 17 3584 CT Utrecht The Netherlands
    • Tel
      31-30-2538800
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock
    cache time: 2024-04-19 22:15:50